64 related articles for article (PubMed ID: 22207963)
1. [NF-kappaB inhibitor].
Nakashima J; Horiguchi Y; Ohno Y; Gondo T; Takeuchi H; Tachibana M
Nihon Rinsho; 2011 Jun; 69 Suppl 5():160-4. PubMed ID: 22207963
[No Abstract] [Full Text] [Related]
2. Antitumor effect of a novel nuclear factor-kappa B activation inhibitor in bladder cancer cells.
Horiguchi Y; Kuroda K; Nakashima J; Murai M; Umezawa K
Expert Rev Anticancer Ther; 2003 Dec; 3(6):793-8. PubMed ID: 14686701
[TBL] [Abstract][Full Text] [Related]
3. Possible role of peritoneal NF-κB in peripheral inflammation and cancer: lessons from the inhibitor DHMEQ.
Umezawa K
Biomed Pharmacother; 2011 Jul; 65(4):252-9. PubMed ID: 21723080
[TBL] [Abstract][Full Text] [Related]
4. Combating endometriosis by blocking proteasome and nuclear factor-kappaB pathways.
Cvek B
Hum Reprod; 2009 Nov; 24(11):2967; author reply 2967-8. PubMed ID: 19687055
[No Abstract] [Full Text] [Related]
5. Can NF-kappaB be a target for novel and efficient anti-cancer agents?
Olivier S; Robe P; Bours V
Biochem Pharmacol; 2006 Oct; 72(9):1054-68. PubMed ID: 16973133
[TBL] [Abstract][Full Text] [Related]
6. Suppression of hormone-refractory prostate cancer by a novel nuclear factor kappaB inhibitor in nude mice.
Kikuchi E; Horiguchi Y; Nakashima J; Kuroda K; Oya M; Ohigashi T; Takahashi N; Shima Y; Umezawa K; Murai M
Cancer Res; 2003 Jan; 63(1):107-10. PubMed ID: 12517785
[TBL] [Abstract][Full Text] [Related]
7. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
[TBL] [Abstract][Full Text] [Related]
8. Blocking NF-kappaB as a potential strategy to treat adult T-cell leukemia/lymphoma.
Horie R; Watanabe T; Umezawa K
Drug News Perspect; 2006 May; 19(4):201-9. PubMed ID: 16823495
[TBL] [Abstract][Full Text] [Related]
9. Combating endometriosis by blocking proteasome and nuclear factor-kappaB pathways.
Celik O; Hascalik S; Elter K; Tagluk ME; Gurates B; Aydin NE
Hum Reprod; 2008 Nov; 23(11):2458-65. PubMed ID: 18676981
[TBL] [Abstract][Full Text] [Related]
10. Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
Ueki S; Yamashita K; Aoyagi T; Haga S; Suzuki T; Itoh T; Taniguchi M; Shimamura T; Furukawa H; Ozaki M; Umezawa K; Todo S
Transplantation; 2006 Dec; 82(12):1720-7. PubMed ID: 17198266
[TBL] [Abstract][Full Text] [Related]
11. Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines.
Morais C; Pat B; Gobe G; Johnson DW; Healy H
Nephrol Dial Transplant; 2006 Dec; 21(12):3377-88. PubMed ID: 16998220
[TBL] [Abstract][Full Text] [Related]
12. Effect of a small molecule inhibitor of nuclear factor-kappaB nuclear translocation in a murine model of arthritis and cultured human synovial cells.
Wakamatsu K; Nanki T; Miyasaka N; Umezawa K; Kubota T
Arthritis Res Ther; 2005; 7(6):R1348-59. PubMed ID: 16277688
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of nuclear factor kappa B attenuates tumour progression in an animal model of renal cell carcinoma.
Morais C; Healy H; Johnson DW; Gobe G
Nephrol Dial Transplant; 2010 May; 25(5):1462-74. PubMed ID: 20037166
[TBL] [Abstract][Full Text] [Related]
14. Prevention of cancer cachexia by a novel nuclear factor {kappa}B inhibitor in prostate cancer.
Kuroda K; Horiguchi Y; Nakashima J; Kikuchi E; Kanao K; Miyajima A; Ohigashi T; Umezawa K; Murai M
Clin Cancer Res; 2005 Aug; 11(15):5590-4. PubMed ID: 16061877
[TBL] [Abstract][Full Text] [Related]
15. Perinatal inhibition of NF-kappaB has long-term antihypertensive effects in spontaneously hypertensive rats.
Koeners MP; Braam B; Joles JA
J Hypertens; 2011 Jun; 29(6):1160-6. PubMed ID: 21505356
[TBL] [Abstract][Full Text] [Related]
16. The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells.
Pajonk F; Himmelsbach J; Riess K; Sommer A; McBride WH
Cancer Res; 2002 Sep; 62(18):5230-5. PubMed ID: 12234989
[TBL] [Abstract][Full Text] [Related]
17. [Proteasome inhibitor bortezomib as an anticancer drug].
Yasui H; Hideshima T
Tanpakushitsu Kakusan Koso; 2006 Aug; 51(10 Suppl):1251-6. PubMed ID: 16922383
[No Abstract] [Full Text] [Related]
18. NF-κB as a potential therapeutic target in myelodysplastic syndromes and acute myeloid leukemia.
Breccia M; Alimena G
Expert Opin Ther Targets; 2010 Nov; 14(11):1157-76. PubMed ID: 20858024
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor-kappaB inhibition by pyrrolidinedithiocarbamate attenuates gastric ischemia-reperfusion injury in rats.
El Eter E; Hagar HH; Al-Tuwaijiri A; Arafa M
Can J Physiol Pharmacol; 2005 Jun; 83(6):483-92. PubMed ID: 16049548
[TBL] [Abstract][Full Text] [Related]
20. The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhibitor?
Cvek B; Dvorak Z
Drug Discov Today; 2008 Aug; 13(15-16):716-22. PubMed ID: 18579431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
